[1]
Firstenberg, M.S., Dyke, C.M., Angiolillo, D.J., Ramaiah, C., Price, M., Brtko, M., Welsby, I., Chandna, H., Holmes, D.R., Voeltz, M., Tummala, P., Hutyra, M., Manoukian, S.V., Prats, J., Todd, M., Liu, T., Chronos, N., Dietrich, M., Montalescot, G., Cannon, L.A. and Topo, E.J. 2015. Safety and Efficacy of Cangrelor, an Intravenous, Short-Acting Platelet Inhibitor in Patients Requiring Coronary Artery Bypass Surgery. The Heart Surgery Forum. 16, 2 (Apr. 2015), E60-E69. DOI:https://doi.org/10.1532/HSF98.20121103.